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Compound Synthesis
General information of synthesis :
Unless otherwise mentioned, all reactions were carried out under a nitrogen atmosphere with dry solvents under anhydrous conditions. The used solvents were purified and dried according to common procedures. Yields refer to chromatographically and spectroscopically ( 1 H NMR) homogeneous materials, unless otherwise stated. Reactions were monitored by thin-layer chromatography carried out on 0.25 mm Tsingdao silica gel plates (60F-254).Visualization was achieved using UV light, phosphomolybdic acid in ethanol or potassium permanganate in water, each followed by heating.
Tsingdao silica gel (60, particle size 0.040 − 0.063 mm) was used for flash column chromatography.
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br. = broad, m = multiplet), coupling constants and integration.
Synthesis and information of micheliolide (MCL), S-MCL, DMAMCL, biotion-S-MCL and biotin-MCL:
MCL were prepared in high yield using our modified method. 2 S-MCL, DMAMCL were prepared according to our previous report. 3 Synthesis of compound 6. 5-Hexynoic Acid (1.12 g, 10 mmol) was dissolved in anhydrous CH 2 Cl 2 (20 mL), and oxalyl chloride (3.7 mL, 60 mmol) were added to the solution. The reaction mixture was stirred under reflex for 1.5 h, cooled to room temperature, concentrated on a rotary evaporator to remove the solvent and residual oxalyl chloride. The acid chloride 5 thus obtained was then re-dissolved in anhydrous CH 2 Cl 2 (30 mL), pyridine (2.6 mL, 32 mmol) was added to the solution, cooled to 0ºC, micheliolide (2.8 g, 11.6 mmol) was added to the solution followed by 
Pull-down of biotin-MCL bound proteins
HL-60 cells were harvested and lysed in RIPA buffer supplemented with protease inhibitors (Calbiochem, Darmstadt, Germany) with brief sonication. After centrifugation at 14,000 g for 10 minutes, the supernatant (1.5 mg/mL) was collected and equally divided into four parts, two of them 
Molecular modeling
The initial apo tetrameric structure was obtained from the Protein Data Bank X-ray structure (PDB ID: 1ZJH). The initial FBP bound tetrameric structure was retrieved from the PDB ID code 1T5A 5 . The missing N-terminal helical region (residues 13-14) in 1ZJH was modeled with Modeler 9.15 6 using 1T5A 5 as a template. The missing mono-and divalent ions (Mg 2+ and K + ) in 1ZJH that are required for PKM2 activity were placed by aligning 1T5A onto 1ZJH. The crystal structure of PKM2 in complex with FBP (PDB ID: 1T5A) was used to model MCL-bound structure. To model MCL-bound PKM2, MCL was covalently docked to cysteine 424 in the tetrameric 1T5A using GOLD 5.1 7, 8 . GOLD defines a "link atom" both in the ligand and in the protein and forces the ligand link atom to occupy the same steric volume as the protein link atom to mimic the covalent binding event. The best scoring conformation was selected. Each monomer had one MCL bound. A total of two systems were created for further molecular dynamic (MD) simulations to properly evaluate the impact of MCL on PKM2.
They are referred to as PKM2 (apo) and PKM2•MCL•FBP (MCL bound tetramer).
All energy minimizations and molecular dynamics simulations were performed with AMBER 14 9 .
The force fields used were ff14SB for the protein 10 and gaff parameters for the ligands (MCL) 11 .
Hydrogen atoms were added to the models with the tLeap module of AMBER 14. Each system was S7 solvated with water molecules, 12 with a minimum distance of 10.0 Å from the surface atoms of the complex to the edge of the periodic simulation box. Counter ions were added to neutralize the net charge of the complex. First, the water atoms and counter ions were minimized for 15000 steps of steepest descent and 10000 steps of conjugate gradient while restraining all other atoms with a force constant of 500 kcal/mol Å 2 . Finally, the whole systems were successively allowed to move. The particle mesh Ewald (PME) method 13 was used to treat long-range electrostatic interactions, with a cubic B-spline interpolation. The cutoff for nonbonded interactions was 10 Å. SHAKE was used to constrain all bonds involving hydrogen atoms (All bonds involving hydrogen atoms were constrained using the LINCS algorithm). The time steps were 1 fs during the equilibration. The temperature of the simulated systems was then gradually increased to 300 K over 50 ps in the NVT ensemble with the Langevin themostat 14 . After the system was heated to 300 K, equilibrating calculation was executed at 1 atm and at 300 K using the NPT ensemble for a total of 1.0 ns. Subsequently, 100 ns production runs for each system were carried out in the isothermal isobaric ensemble (p = 1 atm and T = 300 K). We utilized hydrogen mass repartitioning (HMR) as a method to increase the time step of the MD simulation by a factor of 2 during the production runs 15 . NMR restraints were applied between Mg
2+
and K + and their coordinating ligands by maintaining the metal geometry in 1T5A. Data were analyzed using the CPPTRAJ code in AMBER14 and TCL scripts in VMD.
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Binding energy calculation
To calculate binding energies for dimer (CC'), tetramer (AA') interfaces ligand with PKM2, we used the molecular mechanics combined with the generalized Born and surface area continuum solvation (MM/GBSA) method 17, 18 . The MM/GBSA method combines molecular mechanics, generalized Born electrostatics for polar solvation free energy, nonpolar solvation energy based on solvent-accessible surface area, and normal-mode analyses for entropy to calculate the binding free energy for the protein complexes. For the purposes of MM/GBSA analysis, we sampled frames at 40 ps intervals from the last 40 ns of the MD trajectories (the first 60 ns were discarded as equilibration). In total, 1000 frames were used for averaging. MM/GBSA energy decomposition was further carried out to pinpoint residues (1D decomposition) contributing significantly toward the PKM2 AA' and CC' interface binding energy.
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Western blot
Proteins were separated by SDS-PAGE before being transferred to PVDF membrane (Bio-Rad) 
Preparation of recombinant proteins
The expression of PKM1 and PKM2 from E. coli were carried out as previously described.
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Plasmids pET28a-PKM1, pET28a-PKM2 and mutant pET28a-C424S-PKM2 were transformed to E. coli strain BL21. BL21 strains containing corresponding plasmids were cultured containing 100 µg/mL kanamycin at 37°C to an absorbance of 0.5-0.8 at 600 nm, and induced with 0.5 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) at 18°C for 15-20 hours before being harvested by centrifugation.
The cell pellets were suspended in lysis buffer (10 mM HEPES, pH 7.5; 300 mM KCl; 5 mM imidazole, 5 mM MgCl 2 ; 5% glycerol; 2.5 mM TCEP)) and disrupted by sonication. After centrifugation, the supernatant was applied to a Ni-beads column (QIAGEN, Valencia, CA, USA) and washed 10 times with wash buffer (10 mM HEPES, pH 7.5; 300 mM KCl; 40 mM imidazole, 5 mM S9 MgCl 2 ; 5% glycerol; 2.5 mM TCEP). Proteins were eluted with elution buffer (10 mM HEPES, pH 7.5; 300 mM KCl; 300 mM imidazole, 5 mM MgCl 2 ; 5% glycerol; 2.5 mM TCEP). The fractions eluted from Ni-NTA column were pooled, concentrated, and loaded onto a Superdex 200 10/300 GL column (GE, 17-5175-01) pre-equilibrated with 10 mM HEPES, pH 7.5; 100 mM KCl; 5 mM MgCl 2 ; 5% glycerol; 2.5 mM TCEP. The fractions containing target proteins were collected, concentrated to 20 mg/mL using Amicon Ultra-15 centrifugal filter device (Millipore), and stored at -80°C until use.
Gel filtration of cell fraction
HL60 Cells were treated with DMSO, MCL (5 µM), pervanadate, and MCL combined pervanadate and then extracted in a lysis buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl, 0.3% Nonidet P-40, and 1 mM phenylmethylsulfonyl fluoride (PMSF) for 30 min and centrifuged (30 min at 13,000 rpm)
to remove cell debris. The gel filtration column Hi Prep 16/60 Sephacryl S200 HR column (GE) was washed and equilibrated by cold PBS. Extracts were passed over the gel filtration column. The speed rate of flow is 0.5 ml/min. Fractions were collected every 0.3 ml per tube and analyzed by western blot.
Molecular mass was determined by Gel Filtration Calibration Kit HMW (GE Healthcare).
Recombinant PKM2 activity assay
The activity of recombinant PKM2 (0.1 mg/mL) was determined by a lactate dehydrogenase coupled assay. The change in absorbance at 340 nm resulting from the oxidation of NADH was measured via a pyruvate kinase assay kit (Sigma, MAK072-1KT), according to the manufacturer's instructions. One unit of catalytic activity induces the oxidation of 1 µmol NADH per minute at 37°C at pH 7.6. For activator screen, compounds were pre-incubated with PKM2 enzyme in reaction buffer at 4℃ for 30 minutes. According to the pyruvate standard curve, we calculated the normalized PKM2 activity.
Protein identification by LC/MS/MS
Pyruvate kinase immunoprecipitates were separated by SDS-PAGE, and the band corresponding to pyruvate kinase by molecular weight was excised, subjected to in-gel trypsin digestion and then analyzed by reversed-phase microcapillary LC/MS/MS analysis. MS/MS spectra were searched against the concatenated target and decoy (reversed) Swiss-Prot protein database using Sequest (Proteomics
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Browser Software, Thermo Fisher Scientific). Peptides passing a false discovery rate threshold of 1% were accepted.
Kinetic determination of PKM2-MCL interaction
The specific interaction between PKM2 and biotin-MCL (3) follows the typical covalent binding scheme [20] [21] , where PKM2 forms initial encounter complex PKM2: biotin-MCL and then form the irreversible covalent linked complex PKM2: biotin-MCL. Two-step model of covalent activation:
To determine the values of k act , the rate constant for PKM2: biotin-MCL formation at saturating
[biotin-MCL], and Ki, the apparent dissociation constant for the initial PKM2: biotin-MCL complex, PKM2 was incubated with large excess of biotin-MCL for different time periods and the covalent linked PKM2: biotin-MCL complexes were analysed by SDS-gel and subsequent western blot using streptavidin-HRP. The protein bands on the gels were quantified by densitometry. Scanning was performed at optimal exposure time where band intensity was proportional to the concentration of protein present. Gel photographic images were stored as GRAYSCALE pictures in the TIFF format and were processed using Quantity One software. Under the pseudo-first order experimental conditions, the reaction follows as the equations:
The reaction rate constants of k obs at different biotin-MCL concentration were obtained by fitting to equation (1) and (2), where [PKM2] 0 is the total concentration of PKM2 added to the solution and
[PKM2] t , PKM2 concentration at time t. The value of k act , and K i , were determined by fitting k obs values to equation (3).
Anti-cancer evaluation in HL60 cells xenografted zebrafish
S11
Xenograft zebrafish model and anti-cancer drug screening carried out as previously described. The details were as follows. The standard mating embryos of zebrafish were used for cell xenoplantation at 2 days after post fertilization (2dpf). HL60 cells were detached from culture dishes using 0.05% trypsin-EDTA and washed twice with PBS were stained with 2 mg/mL CM-Dil diluted in PBS and washed four times (once with FBS, twice with PBS and then once with 10% FBS diluted in PBS).
Staining HL60 cells were counted by microscopy, suspended in 10% FBS. Embryos at 2df were developed into zebrafish with yolk sac. About 300 staining HL60 cells were microinjected into the perivitelline cavity of each zebrafish. 30 fishes were used per group. Results are presented as mean ± SD of triplicates from at least 3 independently performed experiments. The student's t-test was used for comparison between experimental groups. A value of p < 0.05 was considered to be statistically significant. 
